Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1416.6000 24.40 (1.75%)
NSE Jun 25, 2026 15:31 PM
Volume: 269.4K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1416.60
1.75%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 84.49% in the last 3 Months
More from Rubicon Research Ltd.
Recommended
Five Interesting Stocks Today - June 26, 2026
The Baseline | 26 Jun 2026, 05:04PM
Market closes higher on easing crude oil prices
Trendlyne Marketwatch | 25 Jun 2026
The companies with the deepest pockets in the current market
The Baseline | 25 Jun 2026